Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  CNS drug reviews

• Publication date

  2006-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/J.1527-3458.2006.00208.XPMID 17227287PMCID PMC2151200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.

  2007cited by this paper
• A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans.

  2007cited by this paper
• Clinical Perspectives on the Combination of D-Cycloserine and Cognitive-Behavioral Therapy for the Treatment of Anxiety Disorders

  2007cited by this paper
• Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

  2006cited by this paper
• Combined Psychotherapy and Pharmacotherapy for Mood and Anxiety Disorders in Adults: Review and Analysis

  2006cited by this paper
• Functional magnetic resonance imaging studies of schizophrenic patients during word production: effects of D-cycloserine.

  2005cited by this paper
• A six-month, placebo-controlled trial of d-cycloserine co-administered with conventional antipsychotics in schizophrenia patients

  2005cited by this paper
• Facilitation of Extinction of Conditioned Fear by D-Cycloserine

  2005cited by this paper
• ects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats

  2005cited by this paper
• Selective Cognitive Impairments Associated with NMDA Receptor Blockade in Humans

  2005cited by this paper
• D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement.

  2004cited by this paper
• The Amygdala, the Hippocampus, and Emotional Modulation of Memory

  2004cited by this paper
• Effects of D-cycloserine on negative symptoms in schizophrenia.

  2004cited by this paper
• Making Advances Where It Matters: Improving Outcomes in Mood and Anxiety Disorders

  2004cited by this paper
• Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.

  2004influential reference
• A pilot study of D-cycloserine in subjects with autistic disorder.

  2004cited by this paper
• Role of NMDA Receptor Subtypes in Governing the Direction of Hippocampal Synaptic Plasticity

  2004cited by this paper
• Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications.

  2004cited by this paper
• Effects of D-cycloserine on extinction of conditioned freezing.

  2003cited by this paper
• Associative Plasticity in Neurons of the Lateral Amygdala during Auditory Fear Conditioning

  2003cited by this paper
• Role of the Amygdala in Fear Extinction Measured with Potentiated Startle

  2003cited by this paper
• Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination?

  2002cited by this paper
• Behavioral and neural analysis of extinction.

  2002cited by this paper
• D-cycloserine for Alzheimer's disease.

  2002cited by this paper
• Facilitation of Conditioned Fear Extinction by Systemic Administration or Intra-Amygdala Infusions of d-Cycloserine as Assessed with Fear-Potentiated Startle in Rats

  2002cited by this paper
• Context, ambiguity, and unlearning: sources of relapse after behavioral extinction.

  2002cited by this paper
• The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction.

  2002cited by this paper
• RS 67333 and D-cycloserine accelerate learning acquisition in the rat.

  2001cited by this paper
• Amygdalar NMDA Receptors Are Critical for the Expression of Multiple Conditioned Fear Responses

  2001cited by this paper
• Consolidation of Extinction Learning Involves Transfer from NMDA-Independent to NMDA-Dependent Memory

  2001cited by this paper
• The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.

  2001cited by this paper
• Intra-Amygdala Blockade of the NR2B Subunit of the NMDA Receptor Disrupts the Acquisition But Not the Expression of Fear Conditioning

  2001cited by this paper
• Pharmacokinetics of Cycloserine under Fasting Conditions and with High‐Fat Meal, Orange Juice, and Antacids

  2001cited by this paper
• Calcium stores regulate the polarity and input specificity of synaptic modification

  2000cited by this paper
• De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder.

  2000cited by this paper
• IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans.

  2000cited by this paper
• Effects of D-cycloserine, a positive modulator of N-methyl-D-aspartate receptors, and ST 587, a putative alpha-1 adrenergic agonist, individually and in combination, on the non-delayed and delayed foraging behaviour of rats assessed in the radial arm maze

  1999cited by this paper
• Is the Amygdala a Locus Viewpoint of “ Conditioned Fear ” ? Some Questions and

  1999cited by this paper
• Why We Think Plasticity Underlying Viewpoint Pavlovian Fear Conditioning Occurs in the Basolateral Amygdala

  1999cited by this paper
• Long-term potentiation--a decade of progress?

  1999cited by this paper
• d-Cycloserine: effects on long-term retention of a conditioned response and on memory for contextual attributes.

  1999cited by this paper
• A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.

  1999cited by this paper
• Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.

  1999cited by this paper
• Evidence for a Tetrameric Structure of Recombinant NMDA Receptors

  1998cited by this paper
• The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B).

  1997cited by this paper
• d-Cycloserine enhances implicit memory in Alzheimer patients

  1996cited by this paper
• Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients.

  1996cited by this paper
• One-session group treatment of spider phobia.

  1996cited by this paper
• Social phobia.

  1995cited by this paper
• NMDA and non-NMDA receptors contribute to synaptic transmission between the medial geniculate body and the lateral nucleus of the amygdala

  1995cited by this paper
• Evaluation of Cycloserine in the Treatment of Alzheimer's Disease

  1995cited by this paper
• Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

  1994cited by this paper
• D‐Cycloserine Treatment of Alzheimer Disease

  1994cited by this paper
• Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention.

  1994cited by this paper
• Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures.

  1993cited by this paper
• Calcium permeability of the N-methyl-D-aspartate receptor channel in hippocampal neurons in culture.

  1993cited by this paper
• A synaptic model of memory: long-term potentiation in the hippocampus

  1993cited by this paper
• Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala

  1992cited by this paper
• The organization of behavior.

  1992cited by this paper
• A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory.

  1989cited by this paper
• An empirically derived inventory to measure social fears and anxiety: The Social Phobia and Anxiety Inventory.

  1989cited by this paper
• Social phobia.

  1987cited by this paper
• NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones

  1986cited by this paper
• Magnesium gates glutamate-activated channels in mouse central neurones

  1984cited by this paper
• Excitatory amino acids in synaptic transmission in the Schaffer collateral‐commissural pathway of the rat hippocampus.

  1983cited by this paper
• Intracellular injections of EGTA block induction of hippocampal long-term potentiation

  1983cited by this paper
• Absorption, distribution, and excretion of cycloserine in man.

  1955cited by this paper

• Predicting treatment response to cognitive behavior therapy in social anxiety disorder on the basis of demographics, psychiatric history, and scales: A machine learning approach

  2025cites this paper
• New Approaches to Addiction Treatment Based on Learning and Memory.

  2023cites this paper
• Psychosocial impacts of caring for a child with a genetic disorder in Accra, Ghana

  2023cites this paper
• Targeting NMDA Receptors in Emotional Disorders: Their Role in Neuroprotection

  2022cites this paper
• Enhancing Psychological Interventions for Post-Traumatic Stress Disorder (PTSD) Treatment with Memory Influencing Drugs

  2022cites this paper
• A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder

  2022cites this paper
• NMDA receptor-mediated processing in inferior frontal gyrus facilitates acquisition and extinction learning and strengthens renewal.

  2022cites this paper
• NRX-101, a Rapid-Acting Anti-Depressant, Does Not Cause Neurotoxicity Following Ketamine Administration in Preclinical Models

  2022cites this paper
• Parsing neural circuits of fear learning and extinction across basic and clinical neuroscience: towards better translation.

  2021cites this paper
• Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels

  2021cites this paper
• Randomized controlled trial of d-cycloserine in cocaine dependence: Effects on contingency management and cue-induced cocaine craving in a naturalistic setting.

  2020influential citation
• Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)

  2019cites this paper
• PRBM_A_211117 1167..1174

  2019cites this paper
• Exposure and Response Prevention in the Treatment of Obsessive-Compulsive Disorder: Current Perspectives

  2019cites this paper
• Investigating a Novel Thalamo-Amygdala Circuit for the Regulation of a Drug-Cue-Specific Memory

  2018cites this paper
• D‐Cycloserine Facilitates Reversal in an Animal Model of Post‐traumatic Stress Disorder

  2018cites this paper
• The Black Book of Psychotropic Dosing and Monitoring.

  2018cites this paper
• Anxiety Disorders: Evidence-Based Integrated Biopsychosocial Treatment

  2017cites this paper
• The Efficacy of Augment of D-Cycloserine and Cognitive-behavioral Therapy on Adolescent with one Type of Anxiety Disorders: A Double-blind Randomized Controlled Trial

  2017cites this paper
• d-Cycloserine facilitates extinction learning and enhances extinction-related brain activation.

  2017cites this paper
• D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome

  2017cites this paper
• The role of basal forebrain cholinergic neurons in fear and extinction memory.

  2016cites this paper
• Zur Rolle der Exposition bei der Therapie von Angststörungen

  2015cites this paper
• The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserine.

  2015cites this paper
• СУИЦИДАЛЬНОЕ ПОВЕДЕНИЕ КАК ПОБОЧНЫЙ ЭФФЕКТ ФАРМАКОТЕРАПИИ ЦИКЛОСЕРИНОМ У БОЛЬНЫХ ТУБЕРКУЛЕЗОМ

  2015cites this paper
• D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis

  2015cites this paper
• Randomized, Placebo-Controlled, Double-Blind Pilot Study of D-Cycloserine in Chronic Stroke

  2015cites this paper
• Current Trends in Prescribing Medications for Obsessive-Compulsive Disorder : Best Practices and New Research

  2015influential citation
• Cognitive-Behavior Therapy Outcomes for Obsessive-Compulsive Disorder: Exposure and Response Prevention

  2015cites this paper
• Cognitive Enhancement

  2015cites this paper
• The fear of food measure: a novel measure for use in exposure therapy for eating disorders.

  2015cites this paper
• Social cognition.

  2015cites this paper
• Tau-Mediated NMDA Receptor Impairment Underlies Dysfunction of a Selectively Vulnerable Network in a Mouse Model of Frontotemporal Dementia

  2014cites this paper
• The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related Disorders.

  2014cites this paper
• Does change in distress matter? Mechanisms of change in prolonged exposure for PTSD.

  2014cites this paper
• Does D-Cycloserine Enhance Exposure Therapy for Anxiety Disorders in Humans? A Meta-Analysis

  2014influential citation
• The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories.

  2014cites this paper
• No evidence for enhanced extinction memory consolidation through noradrenergic reuptake inhibition—delayed memory test and reinstatement in human fMRI

  2014cites this paper
• The Role of the Medial Prefrontal Cortex in Regulating Social Familiarity-Induced Anxiolysis

  2014cites this paper
• Combining d-cycloserine with motor training does not result in improved general motor learning in neurologically intact people or in people with stroke.

  2014cites this paper
• Endogenous cortisol levels influence exposure therapy in spider phobia.

  2014cites this paper
• D-Cycloserine Augmented Treatment of Anxiety Disorders in Children and Adolescents: A Review of Preliminary Research

  2014cites this paper
• Neuroscience of fear extinction: implications for assessment and treatment of fear-based and anxiety related disorders.

  2014cites this paper
• Cognitive enhancers for the treatment of anxiety disorders

  2014cites this paper
• Treatment of pediatric anxiety disorders

  2013cites this paper
• Effect of D‐cycloserine in conjunction with fear extinction training on extracellular signal‐regulated kinase activation in the medial prefrontal cortex and amygdala in rat

  2013cites this paper
• Does d-Cycloserine Augmentation of CBT Improve Therapeutic Homework Compliance for Pediatric Obsessive–Compulsive Disorder?

  2013cites this paper
• A randomized, placebo-controlled laboratory study of the effects of d-cycloserine on craving in cocaine-dependent individuals

  2013cites this paper
• xposure therapy in eating disorders revisited

  2013cites this paper
• DIFFICULT‐TO‐TREAT PEDIATRIC OBSESSIVE‐COMPULSIVE DISORDER: FEASIBILITY AND PRELIMINARY RESULTS OF A RANDOMIZED PILOT TRIAL OF d‐CYCLOSERINE‐AUGMENTED BEHAVIOR THERAPY

  2013cites this paper
• D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables.

  2013cites this paper
• [Treating specific childhood phobia in a single session? A systematic review of the literature].

  2013cites this paper
• Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence.

  2013cites this paper
• Imaging the structure of the human anxious brain: a review of findings from neuroscientific personality psychology

  2013cites this paper
• The science of cognitive therapy.

  2013cites this paper
• D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update.

  2012cites this paper
• Simple and efficient synthetic routes to d-cycloserine

  2012cites this paper
• Novel practical synthesis of d-cycloserine

  2012cites this paper
• The Neural Substrates of Fear Extinction

  2012cites this paper
• Cognitive Enhancers in Exposure Therapy for Anxiety and Related Disorders

  2012cites this paper
• Effects of d-Cycloserine on Craving to Alcohol Cues in Problem Drinkers: Preliminary Findings

  2012cites this paper
• Pharmacological interference with metabotropic glutamate receptor subtype 7 but not subtype 5 differentially affects within- and between-session extinction of Pavlovian conditioned fear.

  2012cites this paper
• Novel NMDA receptor modulators: an update

  2012cites this paper
• Traiter la phobie spécifique de l'enfant en une séance ? Une revue systématique de la littérature Treating specific childhood phobia in a single session? A systematic review of the literature

  2012cites this paper
• New perspectives in glutamate and anxiety.

  2012cites this paper
• Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities: emerging evidence.

  2012cites this paper
• 16 – Anxiety disorders

  2012cites this paper
• Exposure Therapy: Promoting Emotional Processing of Pathological Anxiety

  2012cites this paper
• D-cycloserine effects on extinction of conditioned responses to drug-related cues.

  2012influential citation
• A pilot study of the effectiveness of d-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects

  2011cites this paper
• A Review of Psychotherapy for Obsessive-Compulsive Disorder

  2011cites this paper
• Advances in pharmacotherapy for pediatric anxiety disorders

  2011cites this paper
• Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson's disease dementia.

  2011cites this paper
• Cognitive enhancers for anxiety disorders.

  2011cites this paper
• D‐cycloserine facilitates extinction of cocaine self‐administration in rats

  2011cites this paper
• Neuronal Mechanisms Underlying Development of Nicotine Dependence: Implications for Novel Smoking-Cessation Treatments

  2011cites this paper
• A Review of Psychotherapy for Obsessive-Compulsive

  2011cites this paper
• Medial prefrontal cortex activation facilitates re-extinction of fear in rats.

  2011cites this paper
• ratsprefrontal cortex activation facilitates re-extinction of fear in

  2011cites this paper
• Prolonged exposure therapy: past, present, and future

  2011cites this paper
• Structural Determinants of d-Cycloserine Efficacy at the NR1/NR2C NMDA Receptors

  2010cites this paper
• The Effects of Prior Cognitive Control Task Exposure on Responses to Emotional Tasks in Healthy Participants

  2010cites this paper
• The COMTval 158 met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder

  2010cites this paper
• Genetic gating of human fear, fear learning and extinction : Psychophysiological, brain imaging (fMRI) and clinical studies

  2010cites this paper
• The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder

  2010cites this paper
• Stress and amygdala suppression of metaplasticity in the medial prefrontal cortex.

  2010cites this paper
• [Long-term course of treatment strategies in panic disorder: an update narrative review 1999-2010].

  2010cites this paper
• Natural Occurrence and Industrial Applications of d‐Amino Acids: An Overview

  2010cites this paper
• Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder.

  2010cites this paper
• Propranolol and D-cycloserine as adjunctive medications in reducing dental fear in sedation practice.

  2010cites this paper
• Genetic disruptions of Drosophila Pavlovian learning leave extinction learning intact

  2010cites this paper
• Manifesto for a European anxiety disorders research network.

  2010cites this paper
• Cell Wall Targeted Antibiotics

  2010cites this paper
• [Options, limits and ethics of pharmacological neuroenhancement].

  2010cites this paper
• 13 – Anxious Patients

  2010cites this paper
• Funktionelle Bildgebung bei chronischen Schmerzerkrankungen: Implikationen für die Therapie

  2009cites this paper
• AN FMRI STUDY EXAMINING THE EFFECTS OF ACUTE D-CYCLOSERINE ADMINISTRATION ON BRAIN ACTIVATIONS AND COGNITIVE FUNCTIONING IN SPIDER PHOBIA

  2009influential citation
• Extinction of Recent Fear: Behavioral and Neural Mechanisms.

  2009cites this paper
• D-cycloserine into the BLA reverses the impairing effects of exposure to stress on the extinction of contextual fear, but not conditioned taste aversion.

  2009cites this paper
• Psychotherapy for obsessive-compulsive disorder

  2009cites this paper